european medicines agency glp-1 vision loss recommendation november 2025 What is the pipeline for future medications for obesity? EMA finds no link between

If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team

Vitamin C, also known as ascorbic acid, is a water-soluble antioxidant that can neutralize ROS in the aqueous environments of the body, such as the cytoplasm and extracellular fluids

Abbass NJ, Nahlawi R, Shaia JK, Allan KC, Kaelber DC, Talcott KE, et al

Patients with obesity and HFpEF are classified into a separate phenotype due to a specific clinical presentation and haemodynamics

Hepatic, muscle and visceral triglyceride (TG) and whole fish glycogen were assessed by the commercial kit (Jiancheng Biotech Co., China)

doi: 10.1016/S0140-6736(19)31138-9, 92